Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion type Assertion NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_head.
- NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion wasGeneratedBy ECO_0000203 NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_provenance.
- NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion wasDerivedFrom befree-20150227 NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_provenance.
- NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion SIO_000772 24065731 NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_provenance.
- NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion evidence source_evidence_literature NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_provenance.
- NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_assertion description "[Patients with non-small cell lung cancer (NSCLC) with activating EGF receptor (EGFR) mutations initially respond to first-generation reversible EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367083.RAT0_uImXwuL9-euRgSp4vRyHen6Ic5dGMYlBlQVeesXY130_provenance.